Title |
New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor
|
---|---|
Published in |
Revista da Sociedade Brasileira de Medicina Tropical, February 2016
|
DOI | 10.1590/0037-8682-0150-2015 |
Pubmed ID | |
Authors |
Fabiana Schuelter-Trevisol, Graciane Jacinta Schmitt, Jane Martins de Araújo, Liliane Braga de Souza, Juliana Gomes Nazário, Raquel Landuchi Januário, Rogério Sobroza de Mello, Daisson José Trevisol |
Abstract |
New Delhi metallo-beta-lactamase-1 (NDM-1) is a bacterial enzyme that renders the bacteria resistant to a variety of beta-lactam antibiotics. A 20-year-old man was hospitalized several times for surgical treatment and complications caused by a right-sided vestibular schwannoma. Although the patient acquired several multidrug-resistant infections, this study focuses on the NDM-1-producing Acinetobacter spp. infection. As it was resistant to all antimicrobials tested, the medical team developed a 20-day regimen of 750mg/day metronidazole, 2,000,000IU/day polymyxin B, and 100mg/day tigecycline. The treatment was effective, and the patient recovered and was discharged from the hospital. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 4% |
Unknown | 26 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 6 | 22% |
Researcher | 6 | 22% |
Student > Master | 5 | 19% |
Student > Ph. D. Student | 4 | 15% |
Student > Postgraduate | 2 | 7% |
Other | 1 | 4% |
Unknown | 3 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 33% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 19% |
Immunology and Microbiology | 3 | 11% |
Agricultural and Biological Sciences | 2 | 7% |
Biochemistry, Genetics and Molecular Biology | 2 | 7% |
Other | 3 | 11% |
Unknown | 3 | 11% |